Edition:
India

Caladrius Biosciences Inc (CLBS.OQ)

CLBS.OQ on NASDAQ Stock Exchange Capital Market

2.33USD
9:25pm IST
Change (% chg)

$0.07 (+3.10%)
Prev Close
$2.26
Open
$2.33
Day's High
$2.33
Day's Low
$2.33
Volume
115
Avg. Vol
6,229
52-wk High
$6.83
52-wk Low
$2.18

About

Caladrius Biosciences, Inc. is a cell therapy development company with product candidates in development based on multiple technology platforms and targeting autoimmune and cardiology indications. The Company's lead product candidate, CLBS03, is a T regulatory cell (Treg) clinical Phase II therapy targeting adolescents with... (more)

Overall

Beta: 1.44
Market Cap(Mil.): $30.11
Shares Outstanding(Mil.): 10.38
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates